Educational medical graphic combining a pain assessment tool and surgical material. The top section displays a Visual Analog Scale (VAS) used for clinical pain measurement. The scale features a numeric rating from 0 to 10 correlated with descriptive labels and a Wong-Baker style faces scale: 0 (No Pain, dark green smiling face), 1-3 (Mild, light green smiling face), 4-6 (Moderate to Severe, yellow neutral to orange frowning faces), 7-9 (Very Severe, dark orange distressed face), and 10 (Worst Pain Possible, red crying face). Below the scale is a high-resolution photograph of a self-gripping prosthetic mesh used in surgical procedures like inguinal hernia repair. The mesh is composed of a translucent, white synthetic monofilament knit into a diamond-shaped grid. Characteristic micro-grips or bulbous nodes are visible at the strand intersections, designed for sutureless fixation to anatomical tissues. This comparison illustrates tools used for evaluating patient outcomes, specifically postoperative pain levels relative to surgical techniques and materials.

Recommendations	Strength of Recommendation	Quality of Evidence
Analgesia
1) We suggest that, in critically ill pediatric patients 6 yr old and older who are capable of communicating, pain assessment via self-report be routinely performed using the Visual Analog Scale, Numeric Rating Scale, Oucher Scale, or Wong-Baker Faces pain scale.	Conditional	Low
2) We recommend the use of either the Faces, Legs, Activity, Cry, and Consolability or COMFORT-B scales for assessing pain in non-communicative critically ill pediatric patients.	Strong	Moderate
3) We recommend the use of observational pain assessment tools rather than vital signs alone for assessment of postoperative pain in critically ill pediatric patients.	Strong	Moderate
4) We suggest the use of observational pain assessment tools rather than vital signs alone for assessment of procedure-related pain in critically ill pediatric patients.	Conditional	Low
5) We recommend that IV opioids be used as the primary analgesic for treating moderate to severe pain in critically ill pediatric patients.	Strong	Moderate
6) We recommend the addition of an adjunct NSAID (IV or oral) to improve early postoperative analgesia in critically ill pediatric patients.	Strong	Moderate
7) We suggest the addition of an adjunct NSAID agent (IV or oral) to decrease opioid requirements in the immediate postoperative period in critically ill pediatric patients.	Conditional	Low
8) We suggest the addition of adjunct acetaminophen (IV or oral) to improve early postoperative analgesia in critically ill pediatric patients.	Conditional	Low
9) We suggest the addition of adjunct acetaminophen (IV or oral) to decrease opioid requirements in the immediate postoperative period in critically ill pediatric patients.	Conditional	Low
10) We recommend that music therapy be offered to augment analgesia in critically ill postoperative pediatric patients.	Strong	Moderate
11) We recommend that nonnutritive sucking with oral sucrose be offered to neonates and young infants prior to performing invasive procedures.	Strong	High
Sedation
1) We recommend the use of the COMFORT-B Scale or the State Behavioral Scale, to assess level of sedation in mechanically ventilated pediatric patients.	Strong	Moderate
2) We suggest the use of the Richmond Agitation-Sedation Scale to assess level of sedation in mechanically ventilated pediatric patients.	Conditional	Low
3) We suggest that all pediatric patients requiring MV are assigned a target depth of sedation using a validated sedation assessment tool at least once daily.	Conditional	Low
4) We suggest the use of protocolized sedation in all critically ill pediatric patients requiring sedation and/or analgesia during MV.	Conditional	Low
5) The addition of daily sedation interruption to sedation protocolization is not suggested due to lack of improvement in outcomes.	Conditional	Low
6) During the periextubation period when sedation is typically lightened, we suggest the following bundle strategies to decrease risk of inadvertent device removal: a) Assign a target depth of sedation at increasing frequency to adapt to changes inpatient clinical status and communicate strategies to reach titration goal. b) Consider a sedation weaning protocol. c) Consider unit standards for securement of endotracheal tubes and safety plan. d) Restrict nursing workload to facilitate frequent patient monitoring, decrease sedation requirements, and risk of self-harm.	Conditional	Low
7) We suggest the use of alpha2-agonists as the primary sedative class in critically ill pediatric patients requiring MV.	Conditional	Low

Summary : This figure presents a side-by-side comparison of pain, sedation, and delirium assessment and management in pediatric intensive care, organized into four main categories: Assessment, Risk Factors, Complications, and Management. Each category is subdivided for pain, sedation, and delirium, with specific tools, risk factors, complications, and management strategies listed for each. flowchart/table hybrid: # Overall Structure : • The figure is divided into three vertical columns: Pain, Sedation, and Delirium. • Four horizontal sections: Assessment, Risk Factors, Complications, and Management. • Each cell contains bulleted lists of tools, factors, or strategies. # Pain : ## Assessment : • Self-report scales for communicative children: Visual Analog Scale, Numeric Rating Scale, Oucher Scale, Wong-Baker FACES pain scale. • Behavioral/observational scales for non-communicative children: FLACC, COMFORT-B. • Acute vital sign changes with NMBA use; consider NMBA holiday. ## Risk Factors : • Barriers to pain assessment: Developmental delay, altered mental status, mechanical ventilation (MV). ## Complications : • Iatrogenic Withdrawal Syndrome (IWS). ## Management : • Mild/Moderate: Acetaminophen, NSAIDs. • Moderate/Severe: First-line IV opioids, consider fentanyl for renal dysfunction. • Second-line: Improved pain control and opioid sparing (acetaminophen, NSAIDs, alpha-2 agonist). • Non-pharmacologic: Non-nutritive sucking, music therapy, parental presence. # Sedation : ## Assessment : • Arousal/Level of Consciousness: Monitor every 2 hours when on MV. • Comfort-B scale, State Behavioral Scale (SBS), Richmond Agitation-Sedation Scale (RASS). • Targeted sedation: Set goal, titrate sedation. • EEG-based monitoring and vital sign changes with NMBA use. ## Risk Factors : • Complications with over-sedation: Prolonged MV, prolonged PICU stay, delirium, IWS. ## Complications : • Over-sedation: Prolonged MV, delirium, prolonged PICU stay, IWS. ## Management : • Protocolized analgo-sedation may offer benefit. • First-line: Alpha-2 agonist (post-op, non-cardiac). • Second-line: Ketamine, minimize dose (4 mg/kg/h), minimize duration (<48h), benzodiazepines for delirium. • Peri-extubation strategies: Assign wean target, use extubation protocol, create standard for ETT securement, protect bedside nurse availability. # Delirium : ## Assessment : • Acute brain dysfunction: Inattention, fluctuating mental status. • Acute daily screening: Preschool (psCAM-ICU-5), school-age (pCAM-ICU-5), Cornell Assessment of Pediatric Delirium (CAPD). ## Risk Factors : • Predisposing/precipitating: Young age, developmental delay, congenital heart disease, MV, sedative/analgesic use. ## Complications : • Worse outcomes: Longer ICU/hospital stay, greater cost. ## Management : • First-line: Treat medical disease (labs, brain MAPS). • Hypoactive: Over-sedation, lack of sleep. • Hyperactive: Infections. • Second-line: Non-pharmacologic (sleep hygiene, early mobilization, family presence). • Third-line: Minimize sedation exposure, avoid benzodiazepines, consider alpha-2 agonist, may need dexmedetomidine for withdrawal/mood (hypoactive). # Design Encodings : • Blue, purple, and pink colour coding for Pain, Sedation, and Delirium columns. • Section headers highlighted with background shading. • Bulleted lists for clarity. • Icons for assessment, risk factors, complications, and management. # Analysis : • The figure provides a comprehensive, parallel overview of pain, sedation, and delirium management in pediatric critical care. • Each domain is addressed with specific assessment tools, risk factors, complications, and management strategies. • There is emphasis on protocolized approaches, minimizing complications, and integrating non-pharmacologic interventions. • The structure facilitates rapid comparison and highlights the interconnectedness of pain, sedation, and delirium in clinical practice.

KAS 1: Expected pain	Prior to surgery, clinicians should advise patients and others involved in the postoperative care about the expected duration and severity of pain.	Recommendation
KAS 2: Modifying factors	Prior to surgery, clinicians should gather information specific to the patient that modifies severity and/or duration of pain.	Recommendation
KAS 3A: Risk factors for opioid use disorder	Prior to surgery, clinicians should identify risk factors for OUD when analgesia using opioids is anticipated.	Strong recommendation
KAS 3B: Patients at risk for opioid use disorder	In patients at risk for OUD, clinicians should evaluate the need to modify the analgesia plan.	Recommendation
KAS 4: Shared decision making	Clinicians should promote shared decision making by informing patients of the benefits and risks of postoperative pain treatments that include nonopioid analgesics, opioid analgesics, and nonpharmacologic interventions.	Recommendation
KAS 5: Multimodal therapy	Clinicians should develop a multimodal treatment plan for managing postoperative pain.	Recommendation
KAS 6: Nonopioid analgesia	Clinicians should advocate for nonopioid medications as first-line management of pain after otolaryngologic surgery.	Strong recommendation
KAS 7: Opioid prescribing	When treating postoperative pain with opioids, clinicians should limit therapy to the lowest effective dose and the shortest duration.	Recommendation
KAS 8A: Patient feedback	Clinicians should instruct patients and caregivers how to communicate if pain is not controlled or if medication side effects occur.	Recommendation
KAS 8B: Stopping pain medications	Clinicians should educate patients to stop opioids when pain is controlled with nonopioids and to stop all analgesics when pain has resolved.	Recommendation
KAS 9: Storage and disposal of opioids	Clinicians should recommend that patients (or their caregivers) store prescribed opioids securely and dispose of unused opioids through take-back programs or another accepted method.	Strong recommendation
KAS 10: Assessment of pain control with opioids	Clinicians should inquire, within 30 days of surgery, whether the patient has stopped using opioids, has disposed of unused opioids, and was satisfied with the pain management plan.	Recommendation

This clinical research flowchart outlines the methodology for a randomized comparative study in anesthesiology, focusing on postoperative pain management. The protocol begins with the 'Allocation of Patients' into two distinct cohorts of 30 subjects each. Group T (TAP Block Group) receives an ultrasound-guided (USG) bilateral transverse abdominis plane (TAP) block using 20 ml of 0.375% levobupivacaine per side immediately post-surgery. Group O (Opioid Group) receives 100 mg of intravenous (i.v.) tramadol immediately post-surgery. Both experimental pathways converge into a standardized follow-up protocol consisting of three components: administration of rescue analgesia (i.v. tramadol 50 mg) as required, Visual Analog Scale (VAS) scoring for pain assessment, and monitoring of Postoperative Nausea and Vomiting (PONV). This diagram illustrates a clinical trial design comparing regional anesthesia techniques against systemic opioid administration for efficacy in postoperative analgesia.

This clinical photograph captures an intraoperative surgical procedure on a human knee joint, likely during a total knee arthroplasty. The image displays an open surgical site with deep tissue exposure, where metallic surgical retractors are being used to maintain visualization of the periarticular structures. A clinician is performing a local infiltration analgesia (LIA) technique, utilizing a large-volume syringe (approximately 40-50 mL capacity) filled with a clear medicinal cocktail, such as ropivacaine. The solution is being administered via a long, thin-gauge spinal needle into the lateral sleeve of the joint capsule and surrounding soft tissues. The surgical field is prepared with sterile amber-colored iodine-based adhesive drapes and standard green and blue surgical draping. The hands of the surgical team are visible in sterile gloves, highlighting the precise administration of multimodal analgesia aimed at reducing postoperative pain and opioid consumption. This visual serves as a clinical demonstration of periarticular injection sites and surgical pain management protocols in orthopedic surgery.